|
SE9603726D0
(sv)
*
|
1996-10-11 |
1996-10-11 |
Astra Ab |
Novel compounds
|
|
JP2002502831A
(ja)
*
|
1998-02-03 |
2002-01-29 |
イネックス ファーマシューティカルズ コーポレイション |
癌の治療に用いる血清に対して安定なプラスミド脂質粒子の全身供与
|
|
US6410328B1
(en)
|
1998-02-03 |
2002-06-25 |
Protiva Biotherapeutics Inc. |
Sensitizing cells to compounds using lipid-mediated gene and compound delivery
|
|
IL131887A0
(en)
*
|
1999-09-14 |
2001-03-19 |
Dpharm Ltd |
Phospholipid prodrugs of anti-proliferative drugs
|
|
KR20020073494A
(ko)
*
|
1999-12-29 |
2002-09-26 |
더 리전트 오브 더 유니버시티 오브 캘리포니아 |
약물내성 인체 면역결핍 바이러스 감염의 치료
|
|
EP1460082A1
(en)
*
|
2003-03-19 |
2004-09-22 |
Heidelberg Pharma Holding GmbH |
Phospholipid esters of clofarabine derivatives
|
|
JP2008518886A
(ja)
*
|
2004-11-03 |
2008-06-05 |
リプラサム ファーマ アー／エス |
非天然ホスホリパーゼａ２分解性脂質誘導体を含有する脂質ベースの薬剤送達系およびその治療的使用
|
|
NZ554783A
(en)
|
2004-11-15 |
2010-12-24 |
Ceptyr Inc |
Protein tyrosine phosphatase inhibitors and methods of use thereof
|
|
US8101745B2
(en)
|
2004-12-16 |
2012-01-24 |
The Regents Of The University Of California |
Lung-targeted drugs
|
|
WO2007107161A2
(en)
*
|
2006-03-23 |
2007-09-27 |
Liplasome Pharma A/S |
Lipid based drug delivery systems comprising phospholipase a2 degradable lipids that perform an intramolecular cyclization reaction upon hydrolysis
|
|
ES2600792T3
(es)
*
|
2006-05-03 |
2017-02-10 |
Chimerix, Inc. |
Alcoxialquilésteres metabólicamente estables de fosfonatos, fosfonatos nucleosídicos y fosfatos nucleosídicos antivirales o antiproliferativos
|
|
WO2009061208A1
(en)
*
|
2007-11-09 |
2009-05-14 |
Pronova Biopharma Norge As |
Lipid compounds for use in cosmetic products, as food supplement or as a medicament
|
|
EP2070938A1
(en)
*
|
2007-12-13 |
2009-06-17 |
Heidelberg Pharma AG |
Clofarabine dietherphospholipid derivatives
|
|
WO2009085267A1
(en)
*
|
2007-12-27 |
2009-07-09 |
Epiphany Biosciences |
Antiviral compounds
|
|
US8586625B2
(en)
*
|
2008-01-16 |
2013-11-19 |
Anwar Rayan |
Derivatives of taxol and closely related compounds
|
|
EP2147910A1
(en)
*
|
2008-07-15 |
2010-01-27 |
Pronova BioPharma Norge AS |
Novel lipid compounds
|
|
KR101783817B1
(ko)
|
2009-05-08 |
2017-10-23 |
프로노바 바이오파마 너지 에이에스 |
심혈관 질병, 대사 질병, 및 염증성 질환 분야관련 질병의 치료를 위한 다중 불포화 지방산
|
|
US8884027B2
(en)
|
2010-10-22 |
2014-11-11 |
University Of Rochester |
Melampomagnolide B derivatives as antileukemic and cytotoxic agents
|
|
SG10201509127YA
(en)
|
2010-11-05 |
2015-12-30 |
Pronova Biopharma Norge As |
Methods of treatment using lipid compounds
|
|
US11351139B2
(en)
|
2013-02-28 |
2022-06-07 |
Basf As |
Composition comprising a lipid compound, a triglyceride, and a surfactant, and methods of using the same
|
|
KR20150130355A
(ko)
|
2013-03-15 |
2015-11-23 |
더 리전트 오브 더 유니버시티 오브 캘리포니아 |
비환식 뉴클레오사이드 포스포네이트 디에스테르
|
|
MX2016011897A
(es)
|
2014-03-14 |
2017-04-27 |
Alltech Inc |
Composiciones de compuestos selenoorganicos y metodos de uso de los mismos.
|
|
MX377983B
(es)
|
2014-09-15 |
2025-03-04 |
Univ California |
Análogos de nucleótidos.
|
|
CN106999506A
(zh)
|
2014-11-26 |
2017-08-01 |
脉管生物生长有限公司 |
氧化脂质以及纤维化的治疗或预防
|
|
US9771385B2
(en)
*
|
2014-11-26 |
2017-09-26 |
Vascular Biogenics Ltd. |
Oxidized lipids
|
|
FI3265102T3
(fi)
|
2015-03-06 |
2025-10-31 |
Atea Pharmaceuticals Inc |
Beta-d-2'-deoksi-2'-alfa-fluori-2'-beta-c-substituoituja-2-modifioituja-n6-substituoituja puriininukleotideja hcv-hoitoa varten
|
|
AU2016256552B2
(en)
|
2015-04-28 |
2021-04-01 |
Pronova Biopharma Norge As |
Use of structurally enhanced fatty acids containing sulphur for preventing and/or treating non-alcoholic steatohepatitis
|
|
WO2017048252A1
(en)
|
2015-09-15 |
2017-03-23 |
Alltech, Inc. |
Compositions of selenoorganic compounds and methods of use thereof
|
|
EP3875462A1
(en)
|
2015-09-15 |
2021-09-08 |
The Regents of The University of California |
Nucleotide analogs
|
|
WO2018013937A1
(en)
|
2016-07-14 |
2018-01-18 |
Atea Pharmaceuticals, Inc. |
Beta-d-2'-deoxy-2'-alpha-fluoro-2'-beta-c-substituted-4'-fluoro-n6-substituted-6-amino-2-substituted purine nucleotides for the treatment of hepatitis c virus infection
|
|
PT3512863T
(pt)
|
2016-09-07 |
2022-03-09 |
Atea Pharmaceuticals Inc |
Nucleótidos de purina 2'-substituídos-n6-substituídos para tratamento de vírus de rna
|
|
IL308604B2
(en)
|
2017-12-06 |
2025-08-01 |
Basf As |
Fatty acid derivatives for treating non-alcoholic steatohepatitis
|
|
US20220226480A1
(en)
*
|
2019-03-22 |
2022-07-21 |
Integrated Nanotherapeutics Inc. |
Lipid conjugate prepared from scaffold moiety
|
|
US12049474B2
(en)
|
2019-08-22 |
2024-07-30 |
Emory University |
Nucleoside prodrugs and uses related thereto
|
|
WO2021173713A1
(en)
|
2020-02-27 |
2021-09-02 |
Atea Pharmaceuticals, Inc. |
Highly active compounds against covid-19
|
|
US10874687B1
(en)
|
2020-02-27 |
2020-12-29 |
Atea Pharmaceuticals, Inc. |
Highly active compounds against COVID-19
|
|
JP7559223B2
(ja)
|
2020-08-24 |
2024-10-01 |
ギリアード サイエンシーズ， インコーポレイテッド |
リン脂質化合物及びその使用
|
|
TWI925033B
(zh)
|
2020-10-16 |
2026-05-11 |
美商基利科學股份有限公司 |
磷脂化合物及其用途
|
|
KR20250052378A
(ko)
|
2022-07-21 |
2025-04-18 |
안티바 바이오사이언시즈, 인크. |
Hpv 감염 및 hpv-유도 신생물의 치료를 위한 조성물 및 투여 형태
|
|
WO2026151964A1
(en)
|
2025-01-10 |
2026-07-16 |
Atea Pharmaceuticals, Inc. |
Compositions and use thereof in treating hepatitis e infections with beta-d-2'-deoxy-2'-alpha-fluoro-2'-beta-c-substituted-4'-fluoro-n6-substituted-6-amino-2-substituted purine nucleotides
|